home / stock / pbe / pbe news


PBE News and Press, Invesco Dynamic Biotech & Genome From 03/07/22

Stock Information

Company Name: Invesco Dynamic Biotech & Genome
Stock Symbol: PBE
Market: NYSE

Menu

PBE PBE Quote PBE Short PBE News PBE Articles PBE Message Board
Get PBE Alerts

News, Short Squeeze, Breakout and More Instantly...

PBE - Weekly Market Pulse: Oil Shock

Almost every commodity rose in prices last week, as did the dollar. Those two factors - rising dollar and rising commodity prices - mean the likelihood of recession in the coming year has risen significantly in just the last week. There was considerable volatility in stocks last week,...

PBE - The Innovation Inflection Point

We think that the inflection point is now. The past 18 months have accelerated the use of technology both on the consumer and business side - whether it’s in e-commerce, digital banking, or clean energy. Companies that do not have sunk capital in legacy business models are ofte...

PBE - Russia/Ukraine Conflict And Implications On Sector Views

Russia’s invasion of Ukraine, the biggest conventional military attack in Europe since World War II, has wide-ranging implications for economies and markets around the world. Disruptions from this war and the higher energy prices that result could significantly dampen Europe&#x...

PBE - PBE: Neither Lucrative, Nor Competitive

PBE is neither suitable for income seekers, nor for long term investors. Despite being a Genomic revolution fund, it lacks focus, and invested heavily on large cap diverse biotechnology companies. Better biotechnology ETFs of similar nature are available in the market. For f...

PBE - XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...

PBE - Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. For further details see: Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

PBE - When the Price of Invesco Dynamic Biotech & PBE Talks, People Listen

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PBE - Sector Views: How Higher Yields Impact Equity Valuations

The goal of the DDM is to quickly and easily utilize available resources of an asset to understand what the intrinsic value of that asset is based on certain market and company expectations. If the required return component of the equation rises without expectations of higher company ...

PBE - Invesco Dynamic Biotech & PBE Pivot Points

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PBE - Airline-Health Care Rotation

The anticipated end of the pandemic causes volatility because a transition phase will be priced as a new rotation from, for example, defensive staples to healthcare. Healthcare ETFs can add a defense to a portfolio that is overweight cyclicals, energy, and financials. US Airlines ...

Previous 10 Next 10